Farther Finance Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $845 | Hold |
181
| – | – | ﹤0.01% | 3931 |
|
2025
Q1 | $919 | Hold |
181
| – | – | ﹤0.01% | 3635 |
|
2024
Q4 | $614 | Hold |
181
| – | – | ﹤0.01% | 3399 |
|
2024
Q3 | $516 | Buy |
181
+7
| +4% | +$20 | ﹤0.01% | 3414 |
|
2024
Q2 | $378 | Buy |
174
+71
| +69% | +$154 | ﹤0.01% | 3338 |
|
2024
Q1 | $220 | Hold |
103
| – | – | ﹤0.01% | 3247 |
|
2023
Q4 | $242 | Buy |
+103
| New | +$242 | ﹤0.01% | 3185 |
|